Myopericarditis as a presentation of eosinophilic granulomatosus with polyangiitis (EGPA)

BMJ Case Rep. 2019 Aug 15;12(8):e230593. doi: 10.1136/bcr-2019-230593.

Abstract

A 60-year-old woman was admitted to the hospital with worsening dyspnoea, cough and chest pain. This was on a background of weight loss, decreased appetite, mononeuritis multiplex, chronic eosinophilia and a single episode of a non-blanching rash. Investigations demonstrated a raised troponin and ischaemic changes on ECG, and she was therefore initially treated for a presumed myocardial infarction. However, her symptoms failed to improve with treatment for the acute coronary syndrome. A coronary angiogram revealed no significant flow-limiting disease, and further investigations yielded confirmation of raised eosinophils and a positive perinuclear antineutrophil cytoplasmic antibody test. An echocardiogram demonstrated a pericardial effusion, and subsequent cardiac magnetic resonance features were compatible with myopericarditis. In light of these findings, the patient was diagnosed with eosinophilic granulomatous with polyangiitis and commenced on high-dose intravenous methylprednisolone and cyclophosphamide. She made an excellent recovery and remains in remission on azathioprine and a tapering dose of corticosteroids.

Keywords: pericardial disease; vasculitis.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Eosinophilic Granuloma / complications*
  • Eosinophilic Granuloma / drug therapy
  • Female
  • Granulomatosis with Polyangiitis / complications*
  • Granulomatosis with Polyangiitis / drug therapy
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Methylprednisolone / administration & dosage
  • Middle Aged
  • Myocarditis / drug therapy
  • Myocarditis / etiology*
  • Pericarditis / drug therapy
  • Pericarditis / etiology*

Substances

  • Anti-Inflammatory Agents
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Methylprednisolone